INFECTION EVENTS IN MULTIPLE MYELOMA DURING THE EARLY PERIOD OF AUTOLOGOUS STEM CELL TRANSPLANTATION

INFECTION EVENTS IN MULTIPLE MYELOMA DURING THE EARLY PERIOD OF AUTOLOGOUS STEM CELL TRANSPLANTATION

Objective: Multiple myeloma (MM) patients have a high risk of developing infections. In this study, we documented the infec tion events in patients with MM who underwent autologous hae matopoietic stem cell transplantation (AHSCT).Material and Method: Patients who received an induction regi men and...

Full description

Saved in:

Bibliographic Details
Main Authors:	Shirkhan Amikishiyev, Sevgi Kalayoğlu Beşışık, İpek Yönal Hindilerden, Mustafa Nuri Yenerel, Arif Atahan Çağatay, Simge Erdem, Gülkan Özkan, Meliha Nalçacı
Format:	Article
Language:	English
Published:	Istanbul University Press 2024-07-01
Series:	İstanbul Tıp Fakültesi Dergisi
Subjects:	multiple myeloma autologous haematopoietic stem cell transplantation infection febrile neutropenia
Online Access:	https://cdn.istanbul.edu.tr/file/JTA6CLJ8T5/BC7E0490576D438E890866F899BF9D23
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

UPDATE ON THE ROLE OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA
by: Patrizia Tosi, et al.
Published: (2012-01-01)

UPDATE ON THE ROLE OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA
by: Patrizia Tosi, et al.
Published: (2012-11-01)

A SINGLE-CENTER REAL-LIFE EXPERIENCE WITH FIRST-LINE DARATUMUMAB, BORTEZOMIB, CYCLOPHOSPHAMIDE, AND DEXAMETHASONE (DARA-VCD) IN AL AMYLOIDOSIS
by: Metban Mastanzade, et al.
Published: (2024-12-01)

Is neutropenic fever an obstacle to effective stem cell harvesting?
by: Semih Başcı, et al.
Published: (2024-01-01)

COMPARISON OF ANTIMICROBIAL SENSITIVITY TO OLDER AND NEWER QUINOLONES VERSUS PIPERACILLIN-TAZOBACTAM, CEFEPIME AND MEROPENEM IN FEBRILE PATIENTS WITH CANCER IN TWO REFERRAL PEDIATRIC CENTERS IN TEHRAN, IRAN
by: Ali Nateghian, et al.
Published: (2014-06-01)

Optimizing Autologous Stem Cell Transplantation in Multiple Myeloma: The Significance of Pre-Transplant Controlling Nutritional Status Score
by: Sıdıka Gülkan Özkan, et al.
Published: (2025-02-01)

The role of pomalidomide in treatment of relapse and refractory multiple myeloma
by: S. V. Voloshin, et al.
Published: (2022-01-01)

Review of clinical profile and bacterial spectrum and sensitivity patterns of pathogens in febrile neutropenic patients in hematological malignancies: A retrospective analysis from a single center
by: Arun B Karanwal, et al.
Published: (2013-01-01)

Invasive pulmonary aspergillosis- early diagnosis in febrile neutropenic patients using high resolution CT scan of thorax as a screening tool
by: Shruti Prem, et al.
Published: (2014-08-01)

<i>In vitro</i> activity of cefepime / sulbactam and biapenem against Enterobacterales and <i>Pseudomonas aeruginosa</i> isolated from blood culture from patients with hematological diseases: results of a multicenter study
by: G. A. Klyasova, et al.
Published: (2023-05-01)

Adherence to guidelines for antibiotics used in the initial treatment of febrile neutropenia in patients with cancer: a study using health insurance claims database in Japan
by: Kanako Mizuno, et al.
Published: (2025-06-01)

Infección diseminada por Fusarium spp. en un paciente con anemia aplásica
by: Carolina Giraldo, et al.
Published: (2019-02-01)

Improving Prognostic Accuracy of MASCC Score with Lactate and CRP Measurements in Febrile Neutropenic Patients
by: Efe Kanter, et al.
Published: (2025-07-01)

EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA
by: Cumali Yalçın, et al.
Published: (2022-04-01)

Chemotherapy limiting neutropenia. Is prevention required?
by: I. B. Kononenko, et al.
Published: (2022-01-01)

A Retrospective Observational Cohort Analysis of Oncology Patients with Febrile Neutropenia in the Emergency Department of a Tertiary Care Hospital in Oman
by: Badar Al-Aamri, et al.
Published: (2025-01-01)

Chemotherapy-induced neutropenia and its determinants in patients with solid malignancies: A prospective observational study
by: Whitney Joseph J, et al.
Published: (2025-07-01)

Therapy efficacy in multiple myeloma patients received autologous stem cells transplantation as first line therapy
by: Ye. I. Darskaya, et al.
Published: (2014-07-01)

Real-World Data to Assess the Proportion of Patients Admitted for Febrile Neutropenia That Could Be Considered at Low Risk: The Experience of the Centre Hospitalier Universitaire de Québec
by: Tommy Jean, et al.
Published: (2025-02-01)

Can Serial Measurement Enhance the Diagnostic Value of Procalcitonin as a Marker of Gram-negative Bacteremia in Children with Acute Leukemia?
by: Zümrüt Şahbudak Bal, et al.
Published: (2019-06-01)

Clinical profile, treatment, and outcomes of febrile neutropenia in hematologic disorders: a look at 30-day mortality predictors
by: Eskedar Ferdu Azerefegne, et al.
Published: (2025-07-01)

Neutrophil CD64 can be an early predictor for sepsis during febrile neutropenic episodes in children with cancer: a case control study
by: Marwa Zakaria, et al.
Published: (2025-05-01)

Thrombin generation in children with febrile neutropenia
by: Ayça Koca Yozgat, et al.
Published: (2021-04-01)

Efficacy and safety of pegfilgrastim biosimilar MD‐110 in patients with breast cancer receiving chemotherapy: Single‐arm phase III
by: Toshimi Takano, et al.
Published: (2023-10-01)

Level of Knowledge and Incidence of Emergency Oncology: Febrile Neutropenia in Hematologic Cancer Patients Post Chemotherapy: A Descriptive Study
by: Agus Suryaman
Published: (2024-12-01)

Do We Need Meropenem Treatment Beyond 7 Days in Febrile Neutropenic Patients: A Cost-Effectiveness Analysis
by: Leyla Yumrukaya, et al.
Published: (2025-06-01)

Granulocyte colony-stimulating factor (filgrastim) in chemotherapy-induced febrile neutropenia
by: Advani S, et al.
Published: (2010-01-01)

OUTBREAK OF BURKHOLDERIA CEPACIA INFECTION: A SYSTEMATIC STUDY IN A HEMATOLOGY-ONCOLOGY UNIT OF A TERTIARY CARE HOSPITAL FROM EASTERN INDIA.
by: Shuvra Neel Baul, et al.
Published: (2018-09-01)

Interleukin-6 versus C-reactive protein as markers for early detection of bacteremia in febrile neutropenia in pediatric population
by: Manasi Gupta, et al.
Published: (2020-01-01)

Utilizing Viral Metagenomics to Characterize Pathogenic and Commensal Viruses in Pediatric Patients with Febrile Neutropenia
by: Anielly Sarana da Silva, et al.
Published: (2025-02-01)

Autologous stem cell transplantation in patients older than 65 years with multiple myeloma: a real-world study
by: Cristian Maximiliano Seehaus, et al.
Published: (2024-12-01)

Autologous Hematopoietic Cell Transplant as an Effective Treatment Modality for Systemic Sclerosis and Multiple Myeloma
by: Memon H, et al.
Published: (2025-01-01)

Autologous Bone Marrow Transplant in Multiple Myeloma Patient With Bone Marrow Hematopoietic Stem Cell
by: D Santosa, et al.
Published: (2020-12-01)

Autologous Bone Marrow Transplant in Multiple Myeloma Patient With Bone Marrow Hematopoietic Stem Cell
by: D Santosa, et al.
Published: (2020-12-01)

Is Salvage Autologous Stem Cell Transplantation Still a Viable Treatment Option in Relapsed Myeloma Patients?
by: Luka Čemažar, et al.
Published: (2025-05-01)

Tandem autologous hematopoietic stem cell transplantation for patients with multiple myeloma: a systematic review and meta-analysis
by: Hongtao Li, et al.
Published: (2024-12-01)

Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma in the Era of New Drugs
by: OV Pirogova, et al.
Published: (2018-04-01)

Infections in patients with acute luekemia treated with different regimens
by: T. N. Aleksandrova, et al.
Published: (2025-05-01)

Impact of Recovery from Febrile Neutropenia on Intra-Individual Variability in Vancomycin Pharmacokinetics in Pediatric Patients
by: Yukie Takumi, et al.
Published: (2025-06-01)

The diagnostic and prognostic value of angiopoietins compared with C-reactive protein and procalcitonin in children with febrile neutropenia
by: Esra Mimaroğlu, et al.
Published: (2017-08-01)